Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV
- PMID: 32035811
- PMCID: PMC7102579
- DOI: 10.1016/j.jmii.2020.02.001
Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV
Conflict of interest statement
Declaration of Competing Interest The authors declares no conflicts of interest.
Similar articles
-
Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19.Infez Med. 2020 Jun 1;28(suppl 1):6-17. Infez Med. 2020. PMID: 32532933 Review.
-
Emergence of a Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2: Biology and Therapeutic Options.J Clin Microbiol. 2020 Apr 23;58(5):e00187-20. doi: 10.1128/JCM.00187-20. Print 2020 Apr 23. J Clin Microbiol. 2020. PMID: 32161092 Free PMC article. Review.
-
Calling it what it is.Nat Genet. 2020 Apr;52(4):355. doi: 10.1038/s41588-020-0617-2. Nat Genet. 2020. PMID: 32246133 No abstract available.
-
Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review.APMIS. 2020 Jun;128(6):423-432. doi: 10.1111/apm.13047. APMIS. 2020. PMID: 32363707 Review.
-
[Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).].Vopr Virusol. 2020;65(2):62-70. doi: 10.36233/0507-4088-2020-65-2-62-70. Vopr Virusol. 2020. PMID: 32515561 Review. Russian.
Cited by
-
Can The March of COVID-19 be Halted.Indian J Med Microbiol. 2020 Jan-Mar;38(1):128-133. doi: 10.4103/ijmm.IJMM_20_178. Indian J Med Microbiol. 2020. PMID: 32719220 Free PMC article. No abstract available.
-
SARS-CoV-2 in environmental perspective: Occurrence, persistence, surveillance, inactivation and challenges.Chem Eng J. 2021 Feb 1;405:126893. doi: 10.1016/j.cej.2020.126893. Epub 2020 Sep 4. Chem Eng J. 2021. PMID: 32901196 Free PMC article.
-
Acute kidney injury in pregnant women following SARS-CoV-2 infection: A case report from Iran.Respir Med Case Rep. 2020 May 13;30:101090. doi: 10.1016/j.rmcr.2020.101090. eCollection 2020. Respir Med Case Rep. 2020. PMID: 32405454 Free PMC article.
-
Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary infections.Nano Today. 2021 Feb;36:101051. doi: 10.1016/j.nantod.2020.101051. Epub 2020 Dec 4. Nano Today. 2021. PMID: 33519949 Free PMC article. Review.
-
Screening of cryptogamic secondary metabolites as putative inhibitors of SARS-CoV-2 main protease and ribosomal binding domain of spike glycoprotein by molecular docking and molecular dynamics approaches.J Mol Struct. 2021 Sep 15;1240:130506. doi: 10.1016/j.molstruc.2021.130506. Epub 2021 Apr 29. J Mol Struct. 2021. PMID: 33967344 Free PMC article.
References
-
- Lee K.H., Yoo S.G., Cho Y., Kwon D.E., La Y., Han S.H. Characteristics of community-acquired respiratory viruses infections except seasonal influenza in transplant recipients and non-transplant critically ill patients. J Microbiol Immunol Infect. 2019 Jun 19 doi: 10.1016/j.jmii.2019.05.007. [Epub ahead of print] - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous